Evidence map›Paper›PMID 32203142›Full record

ArticleLeukemia2020

Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model.

Stefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, Geoffroy Andrieux, Alexander Keller, Cornelius Miething, Marie Follo, Dietmar Pfeifer, Khalid Shoumariyeh, Claudia Lengerke and 8 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Stefanie Kreutmair *Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Cathrin Klingeberg *Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Teresa PoggioDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Geoffroy AndrieuxGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Alexander KellerDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Cornelius MiethingDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.ORCID http://orcid.org/0000-0003-4699-3805
Marie FolloDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Dietmar PfeiferDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Khalid ShoumariyehDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Claudia LengerkeDivision of Hematology, University Hospital Basel, 4031, Basel, Switzerland.ORCID http://orcid.org/0000-0001-5442-2805
Irene Gonzalez-MenendezDepartment of Pathology and Neuropathology, University of Tübingen, 72076, Tübingen, Germany.
Falko FendDepartment of Pathology and Neuropathology, University of Tübingen, 72076, Tübingen, Germany.ORCID http://orcid.org/0000-0002-5496-293X
Robert ZeiserDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Suzanne D TurnerDepartment of Pathology, University of Cambridge, Cambridge, CB20QQ, UK.ORCID http://orcid.org/0000-0002-8439-4507
Leticia Quintanilla-MartinezDepartment of Pathology and Neuropathology, University of Tübingen, 72076, Tübingen, Germany.
Melanie BoerriesGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-3670-0602
Justus DuysterDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany.
Anna L IllertDepartment of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106, Freiburg, Germany. lena.illert@uniklinik-freiburg.de.
University of Freiburg · DEUniversity of Tübingen · DEGerman Cancer Research Center · DEUniversity Hospital of Basel · CHUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While cancer stem cells are well established in certain hematologic and solid malignancies, their existence in T cell lymphoma is unclear and the origin of disease is not fully understood. To examine the existence of lymphoma stem cells, we utilized a mouse model of anaplastic large cell lymphoma. Established NPM-ALK

Indexed as

Anaplastic Lymphoma KinaseAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell LineDisease Models, AnimalFemaleGene ExpressionKi-1 AntigenLymphoma, Large-Cell, AnaplasticLymphoma, T-CellMaleMiceMice, Inbred C57BLNIH 3T3 CellsStem CellsAnaplastic Lymphoma KinaseKi-1 Antigen

Identifiers

PMID32203142
PMCPMC7685983
OpenAlexW3012010773

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.